Evidence map›Paper›PMID 24391679›Full record

ArticleThe Australasian medical journal2013

Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa in intensive care units.

Arunava Kali, Sreenivasan Srirangaraj, Shailesh Kumar, Hema A Divya, Akhila Kalyani, Sivaraman Umadevi

Abstract read
In one paragraph

Article in The Australasian medical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. NDM-beta-lactamase-1: Where do we stand?The Indian journal of medical research · 2022
    Review
  7. Antimicrobial Susceptibility Profiles amongPathogens (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arunava KaliDepartment of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.
Sreenivasan SrirangarajDepartment of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.
Shailesh KumarDepartment of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.
Hema A DivyaDepartment of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.
Akhila KalyaniDepartment of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.
Sivaraman UmadeviDepartment of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa has emerged as a threat to hospital infection control, due to its multi-drug resistance, especially in intensive care units (ICUs).

aimsThis study was carried out to detect MBL producing P. aeruginosa isolates from medical and surgical ICUs, to compare and evaluate different phenotypic methods currently in use and to determine antibiograms.

methodA prospective study was undertaken to detect MBLs in P. aeruginosa isolates obtained from various clinical samples. A total of 49 strains were recovered from patients admitted in inpatient wards and ICUs, and screened for imipenem resistance by Kirby Bauer disk diffusion method. Detection of MBLs was further done by imipenem-EDTA disk synergy test and combined disk test.

resultsOut of 49 isolates, 11 isolates (22.4 per cent) were imipenem resistant. All 11 imipenem resistant P. aeruginosa strains, when further tested, were positive for MBL production by combined disk test, but, only eight showed positive results by imipenem-EDTA disk synergy test.

conclusionMBL production was the main resistance mechanism in the 11 carbapenem resistant P. aeruginosa isolates collected, with multidrug resistance associating significantly with MBL production in P. aeruginosa from our institution.

Indexed as

infection controlMetallo-beta-lactamasesMultidrug resistancePseudomonas aeruginosa

Identifiers

PMID24391679
PMCPMC3877850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.